An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction

被引：0
|
作者：
M Siavash Dastjerdi
F Kazemi
A Najafian
M Mohammady
A Aminorroaya
M Amini
机构：
[1] Isfahan University of Medical Sciences,Department of Internal Medicine
[2] Isfahan Endocrine & Metabolism Research Center,Department of Internal Medicine
[3] Sedigheh Tahereh Medical Research Complex,undefined
[4] Isfahan University of Medical Sciences,undefined
来源：
International Journal of Obesity | 2007年 / 31卷
关键词：
fluoxetine; metformin; weight reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：713 / 717
页数：4
相关论文
共 50 条
  • [31] An open-label pilot study of a home wearable light therapy device for postpartum depression
    Leslie M. Swanson
    Helen J. Burgess
    Jennifer Zollars
    J. Todd Arnedt
    Archives of Women's Mental Health, 2018, 21 : 583 - 586
  • [32] An open-label pilot study of a home wearable light therapy device for postpartum depression
    Swanson, Leslie M.
    Burgess, Helen J.
    Zollars, Jennifer
    Arnedt, J. Todd
    ARCHIVES OF WOMENS MENTAL HEALTH, 2018, 21 (05) : 583 - 586
  • [33] An Open-Label, Pilot Study of Daily Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy
    Rasmussen, Keith G.
    Johnson, Emily K.
    Kung, Simon
    Farrow, Stacy L.
    Brown, Sarah K.
    Govrik, Michael N.
    Citronowicz, Ron I.
    JOURNAL OF ECT, 2016, 32 (01) : 33 - 37
  • [34] An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis.
    Denton, Christopher P.
    Engelhart, Merete
    Tvede, N.
    Khan, Korsa
    Carreire, Patricia E.
    Gonzalez, F. Diaz
    Van den Hoogen, Frank H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S524 - S524
  • [35] A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women
    Lukes, Andrea
    Migoya, Elizabeth
    Johnson, Brendan
    Lee, Tien-Yi
    Li, Yulan
    Ferreira, Juan Camilo Arjona
    CLINICAL PHARMACOKINETICS, 2023, 62 (08) : 1169 - 1182
  • [36] Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability
    Potkin, SG
    Thyrum, PT
    Bera, R
    Carreon, D
    Alva, G
    Kalali, AH
    Yeh, C
    CLINICAL THERAPEUTICS, 2002, 24 (11) : 1809 - 1823
  • [37] A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women
    Andrea Lukes
    Elizabeth Migoya
    Brendan Johnson
    Tien-Yi Lee
    Yulan Li
    Juan Camilo Arjona Ferreira
    Clinical Pharmacokinetics, 2023, 62 : 1169 - 1182
  • [38] Safety and efficacy of leflunomide plus etanercept combination therapy in patients with rheumatoid arthritis:: Results from an open-label pilot study
    Grünke, M
    Kalden, JR
    Manger, B
    Antoni, CE
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 421 - 421
  • [39] The safety and efficacy of metformin in fragile X syndrome: An open-label study
    Proteau-Lemieux, Melodie
    Lacroix, Angelina
    Galarneau, Luc
    Corbin, Francois
    Lepage, Jean-Francois
    Caku, Artuela
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 110
  • [40] Reduction of Tinnitus Severity by the Centrally Acting Muscle Relaxant Cyclobenzaprine: An Open-Label Pilot Study
    Coelho, Claudia
    Figueiredo, Ricardo
    Frank, Elmar
    Burger, Julia
    Schecklmann, Martin
    Landgrebe, Michael
    Langguth, Berthold
    Belen Elgoyhen, Ana
    AUDIOLOGY AND NEURO-OTOLOGY, 2012, 17 (03) : 179 - 188
12345